Background: The UK Renal Registry (UKRR) assesses blood pressure (BP) control annually for patients receiving Renal Replacement Therapy (RRT) at renal centres in England, Wales and Northern Ireland. Methods: Patients alive and receiving RRT on 31st December 2009 with a BP reading in either the fourth or third quarter of 2009 were included. Summary statistics were calculated for each renal centre and country. Results: Data completeness for BP measurements submitted to the UKRR for all modalities improved from the previous year and was better for HD patients (67% for pre-HD measurements) than for PD patients (44%) or transplant recipients (37%). In 2009, the median pre-and post-HD SBP were 142 mmHg and 129 mmHg respectively. The median SBP of patients on PD was 137 mmHg. 
Introduction
The controversies over the management of blood pressure (BP) amongst patients on renal replacement therapy (RRT) have been extensively discussed in previous reports from the UKRR [1, 2] and elsewhere [3] [4] [5] [6] . Uncertainty in how best to manage fluid balance and BP, particularly in haemodialysis (HD) patients, stems from several factors:
. the association between low BP and premature mortality [7] [8] [9] [10] [11] , almost certainly the result of pre-existing conditions that cause both low BP and a high risk of subsequent mortality, e.g. cardiac failure; . the complex, non-linear relationship between volume status and BP [12] [13] [14] ; . the fact that BP varies markedly during the dialysis cycle, and that neither pre-dialysis nor post-dialysis BP gives reliable estimates of inter-dialytic mean BP [15] ; . the fact that calcification of conduit arteries causes decreased arterial compliance, changing the relationship between peripheral and central pressure and increasing the risk of sub-endocardial ischaemia at low diastolic pressures; . the linkage between nutritional intake and interdialytic weight gain, confounding analyses of interdialytic fluid overload and outcome [16, 17] ; . the complex balance between the harm associated with extracellular volume expansion and the risk of acute dialysis-related hypotension [18] and associated myocardial stunning [19, 20] with rapid ultrafiltration [21] ; . the balance between the contribution of BP-lowering drugs to the risk of intra-dialytic hypotension and their possible cardio-protective effects.
Some of these problems also contribute to uncertainty about the optimal management of BP in peritoneal dialysis (PD) [22, 23] and transplant patients.
Since the last UKRR Report, two meta-analyses of the effects of BP lowering treatment in dialysis patients have been published [24, 25] . Both studies concluded that there is clear evidence of better outcomes amongst patients randomised to receive BP lowering drug treatment, but do not give reliable evidence on the appropriate 'target' BP range amongst patients on dialysis.
The utility of the UKRR database to inform practice in this area is limited by the absence of reliable and complete information on the use of BP lowering drugs and in HD patients, on intra-dialytic weight gain and the frequency of intra-dialytic hypotension. Analyses are therefore limited to systolic and diastolic BP (measured pre-dialysis and post-dialysis in HD patients).
Due to these uncertainties, the Renal Association currently does not set an audit standard for BP in HD patients. The guideline in operation during the period during which the audit data in this chapter were collected [26] stated: Guideline 1.8 C-CVD: Hypertension in dialysis patients Pre-and post-dialysis blood pressure (measured after completion of dialysis, including washback) should be recorded and intra-dialytic blood pressure measured to enable management of the haemodialysis session.
Measurement of inter-dialytic blood pressure should be encouraged as a routine aid to management in haemodialysis patients (Good Practice).
Blood pressure in peritoneal dialysis patients should be <130/80 mmHg (Good Practice).
Hypertension on dialysis should be managed by ultrafiltration in the first instance (Good practice).
Guideline 1.9 C-CVD: Hypertension in renal transplant patients
The target blood pressure for renal transplant patients is <130/80 mmHg (Good practice).
These guidelines are consistent with international guidelines [6, 27] .
In previous UKRR annual reports, the BP chapter contained numerous separate analyses of pre-dialysis and post-dialysis systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP), together with analyses of the proportion of patients in each centre meeting BP 'goals' . There was considerable overlap in centre performance against each of these measures. For this report the relationship between these various measures using Rose-Day plots have been analysed, reducing the number of 'caterpillar' plots depicting centre performance. The method of data extraction employed is described in chapter 15 of the 11th UKRR Annual Report [28] . The UKRR extracts quarterly laboratory, clinical and demographic data for all patients receiving RRT in the 63 renal centres in England, Northern Ireland and Wales. Data on some variables from the nine Scottish renal centres are sent annually from the Scottish Renal Registry. However, BP measurements are not received from Scotland and therefore Scottish renal centres are excluded from all BP analyses.
Patients who had been on the same modality and at the same renal centre for 3 months and with a valid BP reading in either the fourth or the third quarter of 2009 were included. This included incident patients starting RRT during 2009 who were still alive on 31st December 2009. Analyses used the last recorded BP from quarter 4, however, if this was missing, the last recorded BP from quarter 3 was used instead.
Analyses were performed on each RRT modality (HD, PD and transplant). Most UK renal centres manage HD, PD and transplant patients. However, Colchester had no PD patients and four centres (Bangor, Colchester, Liverpool Aintree, Wirral) had no transplant patients under their care.
All patients meeting the criteria above were included in the overall national analyses, but renal centres with less than 50% data completeness for any modality, or fewer than 20 patients with results, were excluded from the centre-level analysis for that modality. The number preceding the centre name in each figure corresponds to the percentage of missing data in each centre.
Patients on HD were analysed both by pre-dialysis and postdialysis BP. The BP components analysed included SBP, DBP and PP. The data were analysed to produce summary statistics (mean, median, maximum, minimum). Standard deviation and quartile ranges were also calculated. Median BP and inter-quartile ranges (IQRs) are presented for each analysis as caterpillar plots. In addition to this, the percentage of PD and transplant patients attaining Renal Association Standards for BP (<130/80 mmHg) in individual renal centres and each nation were calculated and are presented with 95% confidence intervals in caterpillar plots.
For the pre-and post-dialysis BP in HD patients, Rose-Day plots are used to show the relationship between the BP mean (SBP and DBP) and the percentage of patients below a given threshold (pre-HD BP <140/90 mmHg and post-HD <130/ 80 mmHg) in each centre. Squared correlation coefficients (R 2 ), indicating the strength of the relationship between the two measurements are given. The value of R 2 can be between 0 and 1 (the better the correlation, the closer the value of R 2 to 1). Chi-squared tests were used in the analyses of the 2009 BP data to test for statistically significant differences between renal centres and between nations. All statistical analyses were performed using SAS version 9.2.
Results

Data completeness
Data extracts were received from all 63 centres in England, Wales and Northern Ireland, four of which do not manage any transplant patients and one centre does not manage PD patients. Data completeness is summarised in table 11.1. Overall, completeness is very similar to that in the previous UKRR Report. However, there were large improvements in data completeness for HD from three centres (Cambridge, London West, Oxford), for PD patients from four centres (Gloucester, Hull, Newry, Swansea) and for transplant patients from seven centres (Derby, Gloucester, Newry, Southend, Sunderland, Swansea, Truro).
BP on each modality Figure 11 .1 gives the median and IQR for SBP, DBP and PP in prevalent HD patients (pre-and post-dialysis), PD and transplant patients.
In 2009, the median pre-and post-HD SBP were 142 mmHg and 129 mmHg respectively. The median SBP of patients on PD was 137 mmHg. Transplant recipients had a median SBP of 134 mmHg. Median DBP were 74 mmHg (pre-HD), 68 mmHg (post-HD), 79 mmHg (PD) and 79 mmHg (Transplant).
Relationship between the centre mean and the proportion above a threshold BP in that centre Rose and Day observed in 1990 that, with a normally distributed variable, the population mean will predict the number of 'deviant' individuals in the population -for instance, the number of people with a serum cholesterol >5 mmol/L within a given population is a linear function of the mean cholesterol within that population (29) . If this is true for BP amongst patients on RRT, then plots of centre-specific mean BP will give very similar information to plots of the proportion of patients in each centre with BP above a certain threshold, for instance SBP>140 mmHg. The distribution of BP in each centre was close to a normal distribution (data not shown). Figure 11 .2 demonstrates that the mean pre-dialysis SBP in a given centre accurately predicted the proportion of individuals in that centre whose pre-dialysis BP was <140 mmHg. Figure 11 .3 shows a very similar relationship between mean SBP and the proportion of individuals with pre-dialysis SBP <140 mmHg and DBP <90 mmHg. Figure 11 .4 shows the relationship between mean predialysis DBP and the proportion of individuals with DBP <90 mmHg.
Figures 11.5, 11.6 and 11.7 give the equivalent analyses for post-dialysis BP measurements. Again, there was a close relationship between mean achieved BP in a given centre and the proportion of patients whose BP was below a given threshold value. These analyses show that it is redundant to show both mean (or median) BP and the proportion of patients whose BP was below a given value.
Centre-specific analyses of BP in haemodialysis patients There remained marked centre variation: the difference between the centres with the lowest and highest median SBP was >30 mmHg. Comparison with previous UKRR Reports showed that in general, the same centres can be found at roughly the same place in the distribution from year to year, suggesting differences in centre practice.
Centre-specific analyses of BP in peritoneal dialysis patients Figures 11.12 and 11.13 illustrate the median and IQR SBP and DBP in each centre supplying data on >50% of eligible patients. Figure 11 .14 gives the proportion of patients meeting the audit standard of BP <130/80 mmHg. The possibility of information bias in these analyses cannot be excluded, since BP data are extracted from the routine clinical record. For instance, BP might only be recorded during acute illness or unscheduled clinic visits. However, it is unlikely that >80% completeness of data returns would be achieved if this were the case.
Centre-specific analysis of BP in transplant patients Figures 11.15 and 11 .16 illustrate the median and IQR SBP and DBP in each centre supplying data on >50% of eligible patients and figure 11.17 illustrates the proportion of patients meeting the audit standard of BP <130/80 mmHg.
As with PD, the possibility of information bias in these analyses cannot be excluded.
Discussion
Blood pressure control in UK patients on RRT remained poor. Amongst patients on HD, this can be explained partly by the uncertainties highlighted in the Introduction. However, amongst patients on PD and those with functioning kidney transplants, there was evidence of an important gap between accepted best practice and current achievement. The reasons for this gap remain to be understood.
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